Overview of Pharma Forecasting Excellence Summit 2008 in Boston

Following on from the huge success of our Sell Out 2007 event in Boston, the 2008 event will take Forecasting Excellence to the next level.

Download theForecaster's latest free report here:

Special Report: The Forecast on Forecasting

Eyeforpharma's Forecasting Excellence Summit 2008 will build on the success of our 2007 flagship event with even more forecasting best-practice, case studies and Road Maps to success.

Interest in having a presenting role at this year's event has already been extremely high. If you are A few confirmed speakers include:

John Grecsek, Director of Finance, World Wide Operations, Pfizer
Bob Draper, Global Forecasting Director, Eli lilly USA
Lars Nordmann, Director of Forecasting, Organon USA
Stefano Malvolti, Global Head of Forecasting, Novartis
Kuntal Baveja, Director of Forecasting-Strategic Global Marketing, Novartis
Eric Rambeaux, VP - Business Strategy & Portfolio, Solvay
Art Cook, Principal, ZS Associates
Graham Clarke, CEO, Immunobiology
Jeanne Penn, Associate Director CTI, Genzyme
Zinta Krumins, Managing Director, Boehringer-Ingelheim

The topics below will be covered at our unique conference:

ALIGN NEW PRODUCT FORECASTS AT BOTH HQ AND AFFILIATE LEVEL AND MANAGE THE "POLITICS OF FORECASTING": Address these issues head-on and discover best practice examples to help you meet these challenges

SELECT APPROPRIATE TOOLS FOR NEW PRODUCT AND IN-MARKET FORECASTS: Drive resource allocation decisions by selecting the right sales and marketing channels for your products

UNDERSTAND MEDICARE PART D AND GAUGE ITS EFFECTS: Analyze variations in plan design, patient behavior and location to drive performance at a local and national level

SELECT THE APPROPRIATE ANALOGUE IN FORECASTING NEW PRODUCTS: Examine options valuation techniques to drive your business

INCORPORATE MARKETING RESEARCH AND PRICING ANALYSIS: Learn how to quantify changes in the market environment or a change in price for accurate forecasts

FORECAST EMERGING MARKETS AND THERAPY AREAS: Understand needs across multiple functional areas, and new and uncertain markets

TIME HORIZONS IN FORECASTING: Create a transition while maintaining a strong growth trajectory throughout a year

INCORORATE RISK AND UNCERTAINTY IN YOUR FORECAST: Model the responsiveness of product potential to changes in R&D resource allocation

REHUMANIZING THE FORECASTING PROCESS: Learn to blend math, market knowledge and gut feeling to produce accurate forecasts based on sound methodology

Please send your ideas, suggestions, proposals to Ed Harris on eharris@eyeforpharma.com (or +44 207 375 7173).